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Abstract
Background: Excessive and inappropriate use of antibiotics in hospitalised patients contributes to the development
and spread of antibiotic resistance. Implementing a stewardship programme to curb the problem requires information
on antibiotic use. This study describes a multicentre point prevalence of antibiotic use among paediatric inpatients in
Ghana.
Methods: Data were extracted from a multicentre point prevalence survey of hospital acquired infections in Ghana.
Data were collected between September 2016 and December 2016 from ten hospitals through inpatient folder and
chart reviews using European Centre for Disease Control (ECDC) adapted data collection instrument. From each site,
data were collected within a 12-h period (8 am to 8 pm) by a primary team of research investigators and a select group
of health professionals from each participating hospital.
Results: Among 716 paediatric inpatients, 506 (70.6%; 95% confidence interval (CI): 67.2 to 74.0%) were on antibiotics.
A significant proportion of antibiotics (82.9%) was prescribed for infants compared to neonates (63.9%) and adolescents
(60.0%). The majority of patients (n= 251, 49.6%) were prescribed two antibiotics at the time of the survey. The top five
classes of antibiotics prescribed were third generation cephalosporins (n = 154, 18.5%) aminoglycosides (n = 149, 17.9%),
second generation cephalosporins (n = 103,12.4%), beta lactam resistant penicillins (n = 83, 10.0%) and nitroimidazoles (n
= 82, 9.9%). The majority of antibiotics (n = 508, 61.0%) were prescribed for community acquired infections. The top three
agents for managing community acquired infections were ceftriaxone (n= 97, 19.1%), gentamicin (n= 85, 16.7%) and
cefuroxime (n= 73, 14.4%).
Conclusion: This study points to high use of antibiotics among paediatric inpatients in Ghana. Cephalosporin use may
offer an important target for reduction through antibiotic stewardship programmes.
Keywords: Antibiotic use, Children, Paediatric, Point prevalence, Ghana
Background
Antibiotic resistance is a public health threat of global
proportions [1]. It is associated with increased costs of
health services, prolonged hospital stays and poor clin-
ical outcomes [2, 3]. There are increasing reports of anti-
biotic resistance in hospital-acquired as well as
community-acquired infections in low resource coun-
tries such as Ghana, with a significant number of cases
reported among children [4–8]. This situation, if not ur-
gently addressed, has the potential to jeopardize gains
made in the management of infectious diseases due to
shortfalls in healthcare financing, poor diagnostic cap-
abilities and non-availability of newer therapeutic agents
for the management of drug resistant bacteria [9].
Antibiotic resistance, though a natural phenomenon,
has been accentuated by inappropriate use of antibiotics
which selects for and contributes to the spread of
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resistant bacteria [10–13]. Strategies that have been pro-
posed to counter antibiotic resistance include improved
infection prevention and control programmes; surveil-
lance of antimicrobial resistance; surveillance of anti-
biotic use; and implementation of antimicrobial
stewardship programmes [1, 14–17].
To develop antimicrobial stewardship programmes,
there is a need to acquire accurate baseline data on anti-
biotic prescription practice [18]. As an alternative to
long term prospective surveillance that is usually not
available in low resource countries, point prevalence sur-
veys of antibiotic use have been found useful in generat-
ing such data [19–21]. This study describes antibiotic
prescribing patterns among hospitalised children and ad-
olescents in Ghana using data from a multicentre point
prevalence survey conducted between September and
December 2016 [22]. We describe antibiotic use across
paediatric age groups and hospital levels, indications for
antibiotic use, and targets for improved antibiotic use
within the population.
Methods
Study design and population
The report presented here on antibiotic use in patients
≤18 years is a sub-analysis to a multicentre point preva-
lence survey of hospital acquired infections. The study
design was a retrospective patient record review using
data collection instrument. The study was conducted
among in-patients at ten hospitals in Ghana between
September and December 2016 [22]. Details of the
methodology have been described elsewhere [22, 23].
Briefly, representative samples of acute care hospitals
were selected, using systematic random sampling, ac-
cording to size and hospital type (teaching/tertiary, re-
gional/secondary, and district/primary hospitals). Each
of the ten regions in Ghana was represented by one hos-
pital. There are 3 teaching hospitals, 10 regional hospi-
tals, and about 162 district hospitals in Ghana [24].
Together these hospitals register a bed occupancy rate
of 60.4% (n = 8195) in 2017 for a total bed capacity of
12,806.
Data collection
Data were collected from patient folders and treatment
charts using standardised forms adapted from the Euro-
pean Centre for Disease Control (ECDC) [23]. Data re-
corded included type of antibiotic administered, route of
administration, indication for use, number of doses per
day, anatomic site targeted and duration of administra-
tion. Medical records of all patients on admission on or
before 8 am on the day of the study were reviewed. Data
collection was conducted within a 12-h period, i.e. 8 am
to 8 pm. For hospitals with large bed capacity (> 1000),
individual wards were investigated within a 12-h period
and the total time frame for data collection at all wards
of the hospital did not exceed one week. Data collection
from each hospital was performed by two teams: a pri-
mary team of research investigators and a selected group
of health professionals from the participating hospital.
Definitions
Data on antibiotic use was recorded when a patient was
actively on antibiotics at the time of the survey. As per
ECDC guidelines, indication for antibiotic use was
assigned to either community acquired infection (infec-
tion with symptoms occurring within 48 h of hospital
admission) or hospital acquired infection (an active in-
fection with signs and symptoms occurring after 48 h of
admission or when the patient presented with an infec-
tion but had been readmitted less than two days after a
previous discharge from a hospital). Unknown indica-
tions included antibiotic treatments with missing infor-
mation on origin of active infection. Diagnosis of
infection was categorised according to anatomic systems
[23, 25]: eye; ear, nose, throat, larynx and mouth (ENT);
respiratory tract (including pneumonia and acute bron-
chitis); cardiovascular system (CVS) including endocar-
ditis and vascular grafts; gastrointestinal tract (GIT);
intra-abdominal organs including those of the hepato-
biliary system; skin, soft tissue, bone and joint (SSTBJ);
central nervous system (CNS); genitourinary and gynae-
cological (GUOB); and those with undefined infection
sites.
Data handling and statistical analysis
Data was analysed using Access (Microsoft Office 2016)
and Statistical Package for Social Sciences (SPSS, Ver-
sion 21.0). Antibiotics were classified according to the
Anatomical Therapeutic Chemical Classification System
(ATC) [26]. We compared prevalence of antibiotic use
across different hospital levels and across different age
groups using the chi-square tests for multiple propor-
tions with Marachuilo post hoc analysis. Two –tailed
p-values < 0.05 were considered statistically significant.
We categorized our study as neonates if ≤28 days; and
infants if > 28 days to ≤2 years. In the Ghanaian health-
care system, patients aged 0 up to 13 years are attended
to in paediatric departments whilst those > 13 years are
seen at adult departments. We thus assigned the term
children if aged > 2 years to ≤13 years, and adolescents if
aged > 13 years to ≤18 years.
Results
Data was collected from 2 tertiary hospitals, 3 secondary
hospitals, and 5 primary hospitals (Table 1). The in-
cluded hospitals had a total 4208 acute care beds, repre-
senting 32.9% of the total bed capacity for government
hospitals in Ghana, and an overall bed occupancy of
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59.1%. The median bed-size in a hospital was 304, ran-
ging from 139 to 1533.
Hospital and patient characteristics
A total of 849 inpatients under the age of 18 years were
included. Among these, 133 neonates were healthy and
only in hospital because their mothers had not been dis-
charged home. None of these received antibiotics and
they were excluded from further analyses, leaving a total
of 716 patients included for analysis. Baseline demo-
graphic data are shown in Table 1. Of the patients, 201
(28.1%) were from district hospitals, 175 (24.4%) from
regional hospitals and 340 (47.5%) from tertiary hospi-
tals. The average duration of stay of the patients prior to
the survey was 8 days, this varied from 5 days in the re-
gional hospitals to 6 days in district hospitals and 9 days
in tertiary hospitals.
Use of antibiotics
Out of 716 patients on admission, 506 [70.6%, confi-
dence interval (CI): 67.2 to 74.0] received at least one
antibiotic at the time of the survey. There was a signifi-
cant difference between the proportions of patients re-
ceiving antibiotics in regional hospitals (83.4%), tertiary
(65.6%) and district hospitals (68.2%, p = 0.0001). The
proportion of antibiotic use among infants (82.9%) was
significantly higher compared to antibiotic use in neo-
nates (63.9%) and adolescents (60.0%) but similar to the
proportion of use among children (72.4%, p = 0.0001,
Table 1). Of patients on antibiotics, the majority (n =
251, 49.6%) were prescribed two antibiotics whereas
fewer received one antibiotic (n = 219, 43.3%), three anti-
biotics (n = 33, 6.5%) or four antibiotics (n = 3, 0.6%).
This trend was observed among the neonatal, infant and
adolescent populations, but not for children who were
more likely to receive one antibiotic (Fig. 1). A total of
831 individual antibiotics were prescribed; 694 (83.5%)
were administered via the intravenous route and 137
(16.5%) via the oral route, which was similar across dis-
trict, regional and tertiary hospitals. Average duration of
antibiotic administration at the time of the survey was 4
days, ranging between 1 and 13 days. Average duration
of antibiotic administration was 3 days for district hospi-
tals, 4 days for regional hospitals and 6 days for tertiary
hospitals.
Antibiotic utilisation at different types of healthcare
facilities
Figure 2 shows antibiotic use by class (ATC Level 4)
across the different hospital types. The top five classes of
antibiotics used (N = 831) were third generation cephalo-
sporins (n = 154, 18.5%), aminoglycosides (n = 149,
17.9%), second generation cephalosporins (n = 103,
12.4%), beta lactam resistant penicillins (n = 83, 10.0%)
and nitroimidazoles (n = 82, 9.9%). The proportion of
third generation cephalosporin used was similar at the
three hospital levels, i.e. tertiary (n = 74, 18.9%), regional
(n = 46, 18.9%), district (n = 34, 17.3%, p = 0.9). Similar
proportions of aminoglycosides were used in tertiary (n
= 84, 21.5%) and regional (n = 39, 16%) hospitals,
whereas significantly lower proportion were used in dis-
trict hospitals (n = 26, 13.2%) compared to tertiary hospi-
tals (p = 0.03). A significantly higher proportion of
second generation cephalosporins were used in district
hospitals (n = 48, 24.4%) compared to tertiary (n = 26,
6.6%) and regional hospitals (n = 29, 11.9%, p = 0.001).
Carbapenems were only used in tertiary hospitals (n = 7,
0.8%). Of third generation cephalosporins prescribed,
ceftriaxone was the commonest (n = 124, 80.5%) com-
pared to ceftazidime (n = 1, 0.6%) and cefpodoxime (n =
1, 0.6%). Among the aminoglycosides, gentamicin (n =
114, 76.5%) and amikacin (n = 35, 23.5%) were the only
prescribed agents, with amikacin being prescribed only
in tertiary hospitals. Cefuroxime (n = 103) was the only
Table 1 Prevalence of antibiotic use by age and across type of hospital
Patient characteristics Number of patients on Prevalence of antibiotic use
Admission (%) Antibiotics Percent 95% CI
Age groupa
≤ 28 days 208 (29.1) 133 63.9 57.0–70.1
> 28 days to ≤2 years 152 (21.2) 126 82.9 75.8–88.3
> 2 years to ≤13 years 272 (40.0) 197 72.4 66.6–77.6
> 13 years to ≤18 years 84 (11.7) 50 60.0 48.2–69.9
Hospital type
Tertiary 340 (47.5) 223 65.6 60.4–70.6
Regional 175 (24.4) 146 83.4 77.2–88.2
District 201 (28.1) 137 68.2 61.4–74.2
Total 716 (100.0) 506 70.6 67.2–74.0
a≤28 days, neonates; > 28 days to ≤2 years, infants; > 2 years to ≤13 years, children; > 13 years to ≤18 years, adolescents; %, percentage, CI confidence interval
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prescribed second generation cephalosporin in all
healthcare facilities. Cloxacillin (n = 83) and metronida-
zole (n = 82) represent the only agents used across all
healthcare facilities in the beta lactam resistant peni-
cillin and nitroimidazole classes respectively. Among
carbapenems, meropenem was the only agent pre-
scribed (n = 7) (Fig. 2).
Antibiotic utilisation among different age groups
The five most common antibiotics used among neonates
were gentamicin (n = 56, 22%); cloxacillin (n = 50,
19.9%); ampicillin (n = 48, 18.9%); amikacin (n = 32,
12.6%); and cefotaxime (n = 25, 9.8%) (Fig. 3). Among in-
fants, ceftriaxone (n = 37, 19.2%), cefuroxime (n = 32,
16.6%), gentamicin (n = 31, 16.1%), ampicillin (n = 13,
6.7%), crystal penicillin (n = 13, 6.7%) and metronidazole
(n = 13, 6.7%) were the top six antibiotics used. Among
children, the five most common antibiotics used were
ceftriaxone (n = 66 (21.8%), cefuroxime (n = 57, 18.8%),
gentamicin (n = 26, 8.5%), ciprofloxacin (n = 24, 7.9%)
and amoxicillin-clavunalic acid (n = 23, 7.6%).
Indication for antibiotic use
Out of the 831 antibiotics prescribed, 508 (61%) were
prescribed for community-acquired infections, 86
(10.3%) for hospital-acquired infections, 197 (23.7%) for
prophylaxis and 40 (4.8%) for unknown reason (Table 2).
The top three agents for managing community-acquired
infections were ceftriaxone (n = 97, 19.1%), gentamicin
(n = 85, 16.7%) and cefuroxime (n = 73, 14.4%). The
common agents used for surgical prophylaxis were
Fig. 2 Antibiotic use by ATC level 4 across hospital category. Others include nitrofurantoin and co-trimoxazole
Fig. 1 Number of antibiotics prescription per patients’age category across hospital type
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metronidazole (n = 20; 28.2%), amoxicillin-clavulanic
acid (n = 15, 21.1%) and cefuroxime (n = 13, 18.3%).
Based on the anatomic site, antibiotics were mainly
prescribed for undefined reasons (n = 328, 39.5%),
followed by the respiratory system (n = 196, 23.6%) and
skin, soft tissue, bone and joint infections (n = 131,
15.8%) (Table 3). Infection without a defined focus
formed the majority of the undefined reasons for anti-
biotic use in neonates. The top three antibiotics used in
managing infections with undefined focus were gentami-
cin (n = 59, 18.0%), ceftriaxone (n = 57, 17.4%) and ampi-
cillin (n = 45, 13.7%). For respiratory tract infections,
gentamicin (n = 35, 17.9%), cefuroxime (n = 34, 17.3%)
and ceftriaxone (n = 2, 14.8%) were the three most com-
monly used antibiotics. The top three antibiotics pre-
scribed for skin, soft tissue, bone and joint purposes
were metronidazole (n = 24, 18.3%), cloxacillin (n = 23,
17.6%) and clindamycin (n = 20, 15.3%).
Discussion
To the best of our knowledge this study presents one of
the few multicentre studies on antibiotic use among hos-
pitalised paediatric patients from Africa and the first
from Ghana. It provides current patterns of antibiotic
prescribing practices in this population in Ghana and
can serve as a baseline for future comparison. We ob-
served that 71% of the hospitalised paediatric and ado-
lescent patients were prescribed antibiotics with a high
percentage of use among infants and neonates. This fig-
ure is comparable to a 69.4% rate of antibiotic use ob-
served among children in a recent single site study from
Korle-bu Teaching Hospital in Ghana [27]. The rate is
comparable to findings from the United States of
America [28], but higher than 36.7% recorded in a re-
cent worldwide survey of antibiotic use in children [29].
The lowest antibiotic use was reported for tertiary hos-
pitals. This may be attributed to the fact that doctors in
tertiary hospitals have more opportunities for rational
antibiotic use: through participation in continuing edu-
cation, consultations with senior physicians, and re-
search [1, 14–17, 30]. Although we accept the possibility
that doctors’ practices on antibiotic use in tertiary hospi-
tals may still be insufficient [27], it is notable that doc-
tors coming from primary healthcare institutions have
poorer knowledge, attitudes and practices on antibiotic
use [31, 32]. Analysis of data from the Chinese Nosoco-
mial Infection Control Surveillance Networks reveals
that, compared with large secondary and tertiary hospi-
tals, excessive and improper use of antibiotics is more
severe in primary health care facilities [33, 34]. In some
European Countries, published data suggest higher anti-
biotic use in tertiary health facilities [25]. The heterogen-
eity in the level antibiotic use across hospital types is
highlighted in the recent study that reviewed published
works and online surveillance reports on antibiotic con-
sumption in acute care hospitals between the years 1997
and 2013 [35]. In their pooled estimate for antibiotic
consumption, there was a non-significant trend for
higher antibiotic consumption in tertiary compared to
non-tertiary hospitals.
In our study, we observed a very high rate of paren-
teral antibiotic use, especially in tertiary hospitals. It has
been suggested that high rates of parenteral antibiotic
use persists among children because of limited options
for oral broad spectrum antibiotics with appropriate for-
mulations and the challenges of oral administration of
Fig. 3 Proportion of antibiotic use (ATC level 5) across patients’ age category
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medications in young children [36]. Similar high rates of
parenteral antibiotic use have been observed in other
settings [18, 27]. Parenteral antibiotic use is a known
quality indicator of antibiotic prescribing practices [21,
37]. Low rates of intravenous antibiotic use are preferred
since they are associated with lower levels of thrombo-
phlebitis, cannula related infections, lower cost of care
and early discharge [37, 38]. There was a high usage of
third and second generation cephalosporins as well as
aminoglycosides among patients in all types of health-
care facilities in the country. This may be due to the
abundance of cheap generic options on the market, as
well as their availability on the national health insurance
scheme at all levels of the health care system [39]. Glo-
bally, cephalosporins are used empirically in patient care
due to their low toxicity, they are however known to
contribute to the development and spread of multi-drug
resistant infections [40]. Extensive use of third gener-
ation cephalosporins among primary and secondary level
facilities may be contributing to the rise and spread of
extended spectrum beta lactamase-producing bacteria in
Ghanaian hospitals [4, 41]. This phenomenon may limit
the usefulness of these agents at the tertiary level in
managing referred cases. Low prescribing rates of antibi-
otics such as carbapenems and vancomycin were ob-
served from this study. These agents were only used in
tertiary healthcare facilities and mainly in one healthcare
facility, the Korle-Bu Teaching Hospital. Low prescrip-
tion rates of these agents could be accounted for by their
unavailability on the national health insurance scheme
and the high cost associated with out of pocket purchase
[39]. This practice has the potential to slow down the
development and spread of carbapenemase-producing
and vancomycin-resistant bacteria among paediatric
patients.
The highest use of gentamicin, amikacin, ampicillin
and cloxacillin was in the neonatal age group. These
agents are recommended by the standard treatment
guidelines of Ghana and by other international guide-
lines for neonatal infections [42, 43]. Our data suggest a
strong adherence to the recommended treatment proto-
cols among the neonatal age group. Similar findings have
been reported in recent studies on antibiotic use among
children [29, 44, 45]. Amikacin use in this study was
accounted for by one tertiary healthcare facility i.e.
Korle-Bu Teaching Hospital. In this facility, amikacin in
combination with cloxacillin forms the standard treat-
ment protocol for infections in the neonatal intensive
care unit. This protocol has been in place for the past 6
years and was instituted after a review of the unit’s anti-
biogram showed increasing resistance to ampicillin/gen-
tamicin combination which was the previously
Table 2 Indications for prescribing antimicrobial drugs (ATCa level 5) and the five most common antibiotics used
Indication for antibiotic use Top 5 antibiotic use among paediatric inpatients
1st 2nd 3rd 4th 5th
All indications (n = 831) Ceftriaxone
(n = 124, 14.9%)
Gentamicin
(n = 114, 13.7%)
Cefuroxime
(n = 103, 12.4%)
Cloxacillin
(n = 83, 9.9%)
Metronidazole
(n = 82, 9.8%)
Community acquired infections (n = 508) Ceftriaxone
(n = 97, 19.1%)
Gentamicin
(n = 85,16.7%)
Cefuroxime
(n = 73, 14.4%)
Cloxacillin
(n = 48, 9.4%)
Metronidazole
(n = 47, 9.3%)
Hosptal acquired infections (n = 86) Cloxacillin
(n = 12, 14.0%)
Gentamicin
(n = 12, 14.0%)
Cefuroxime
(n = 8, 9.3%)
Ciprofloxacin
(n = 7, 8.1%)
Amikacin
(n = 6, 7.0%)
Ampicillin
Ceftriaxone
Meropenem
Medical prophylaxis
(n = 126)
Ampicillin
(n = 17, 13.5%)
Gentamicin
(n = 1, 13.3%)
Cefotaxime
(n = 16, 12.7%)
Amikacin
(n = 14, 11.1%)
Crystal penicillin
(n = 13, 10.3%)
Cloxacillin
Surgical prophylaxis
(n = 71)
Metronidazole
(n = 20, 28.2%)
Amoxicillin-clavulanic acid
(n = 15, 21.1%)
Cefuroxime
(n = 13, 18.3%)
Ceftriaxone
(n = 7,9.9%)
Ampicillin
(n = 4, 5.6%)
Ciprofloxacin
Unknown
(n = 40)
Ceftriaxone
(n = 8, 20.0%)
Amox-clavulanic acid
(n = 4, 10.0%)
Metronidazole
(n = 3, 7.5%)
Amikacin
(n = 2, 5.0%)
Erythromycin
(n = 1, 2.5%)
Ciprofloxacin Cefuroxime Azithromycin
Clindamycin Crystal penicillin Co-trimoxazole
Ampicillin Amoxicillin
Cloxacillin
Gentamicin
aATC Anatomical Therapeutic Chemical Classification System
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recommended standard treatment [46]. In contrast,
there was a sharp difference in the classes of antibiotics
used among the other age groups, they were mainly
treated with broad spectrum agents such as third and
second generation cephalosporins. Antibiotics were
commonly prescribed for infections of undefined origin,
in particular among neonates. This may reflect chal-
lenges with diagnosing infections in neonates with a re-
sultant high rates of empirical antibiotic use.
The use of broad spectrum antibiotics among children
is a quality indicator for antibiotic prescribing as it can
lead to the development and spread of antibiotic resist-
ance [29]. Use of such broad spectrum antibiotics in chil-
dren may reflect the lack of adherence to suggested
standard treatment guidelines. The prescribing pattern
may also be affected by the relatively low utilisation of
microbiology culture services observed in an earlier study
[22]. The limited availability and usage of clinical micro-
biology services thus promotes empirical antibiotic pre-
scribing against susceptibility guided therapy; it also does
not allow for stepping treatment down from broader to
narrower spectrum antibiotics. Several studies in Ghana
have shown an increase in the incidence of infections
caused by extended spectrum beta lactamase-producing
bacteria. This may be a direct result of the high usage of
cephalosporins [4, 6, 41, 47]. Metronidazole, amoxicillin
clavulanic acid and cefuroxime were the most common
antibiotics used for surgical prophylaxis. High use of
metronidazole as a prophylactic agent in surgery practice
has been documented in other studies in Ghana [27, 48].
Metronidazole used in combination with antibiotics with
aerobic coverage has been found to prevent surgical site
infections in abdominal surgeries [49, 50]. Although this
study did not assess the appropriateness of antibiotic pre-
scribing there is evidence that metronidazole
amoxicillin-clavulanic acid combination is commonly used
despite the fact that it represents double cover for anaer-
obic bacteria.
Reducing antibiotic consumption through stewardship
programmes is a major global strategy being advanced
to curb the development and spread of antibiotic resist-
ance [14, 51–55]. In resource limited countries like
Ghana, third generation cephalosporins represent a safe
broad-spectrum agent useful for the management of
very severe Gram negative and positive infections. Our
study highlights third generation cephalosporins as a
major antibiotic class for which antibiotic stewardship
strategies are urgently needed to preserve their useful-
ness among hospitalised paediatric patients. Failure to
preserve these agents may result in increased use of
newer and more expensive agents like carbapenems and
glycopeptides due to growing antibiotic resistance; a
situation which may lead to a reversal of gains made in
the management and control of infectious diseases.
Table 3 Anatomic sites of infection and the five most common antimicrobial drugs (ATC level 5) prescribed
Anatomic
sitesa
Top 5 antibiotic use (ATCa level 5) among paediatric patients
1st 2nd 3rd 4th 5th
Resp
(n = 196)
Gentamicin
(n = 35, 17.9%)
Cefuroxime (n = 34, 17.3%) Ceftriaxone (n = 29, 14.8%) Amox-clav (n = 18, 9.2%) Cloxacillin (n = 12, 6.1%)
C penicillin
SSTBJ (n = 131) Metronidazole
(n = 24,18.3%)
Cloxacillin (n = 23, 17.6%) Clindamycin (n = 20, 15.3%) Cefuroxime (n = 19, 14.5%) Amox-clav (n = 17, 13.0%)
GIT (n = 88) Metronidazole
(n = 29, 32.9%)
Cefuroxime (n = 17,19.3%) Ciprofloxacin (n = 13,14.8%) Ceftriaxone (n = 11,12.5%) Gentamicin (n = 7, 8.0%)
GUOB (n = 33) Metronidazole
(n = 8,24.2%)
Amox-clav (n = 7, 21.2%) Cefuroxime (n = 5, 15.2%) Ceftriaxone (n = 4, 12.1%) Ciprofloxacin (n = 3, 9.1%)
CNS
(n = 26)
Amox-clava
(n = 2, 7.7%)
Ceftriaxone (n = 11, 3.4%) Cloxacillin (n = 5, 1.5%) Metronidazole (n = 3,0.9%) Gentamicin (n = 1, 0.3%)
Cefuroxime Cefotaxime
Meropenem
UTI
(n = 14)
Cefuroxime
(n = 5, 35.7%)
Ciprofloxacin (n = 3, 21.4%) Other drugsb (n = 6, 43.8%) – –
Other sites
(n = 15)
Ceftriaxone
(n = 4, 26.6%)
Amox-clav (n = 2, 13.1%) Other drugsc (n = 4, 26.6%) – –
C penicillina
UND (n = 328) Gentamicin
(n = 59,18.0%)
Ceftriaxone (n = 57, 17.4%) Ampicillin (n = 45,13.7%) Cloxacillin (n = 42,12.8%) Amikacin (n = 25,7.6%)
aResp respiratory tract, GIT Gastrointestinal tract, UTI Urinary tract infection, CNS Central nervous system, SSTBJ skin, soft tissue, bones and joints, GUOB
Genitourinary and obstetrics; Other sites comprise cardiovascular system and Ear, nose and throat; UND Undefined, Amox-clav Amoxicillin-clavulanic acid, C
pencillin Crystal penicillin, ATC Anatomical Therapeutic Chemical Classification System
bother drugs include crystal penicillin (n = 1), ceftriaxone (n = 1), gentamicin (n = 1), meropenem (n = 1), nitrofurantoin (n = 1), erythromycin (n = 1)
cothers include crystal penicillin (n = 1), ceftriaxone (n = 1), gentamicin (n = 1), meropenem (n = 1), nitrofurantoin (n = 1), erythromycin (n = 1)
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There is also the need for improved access to diagnostic
clinical microbiology services which would contribute to
improved diagnosis and management of conditions such
as sepsis and lead to a reduction in antibiotic use.
This study has some potential limitations. Although
the data presented here gives a good situation report of
publicly funded health facilities, findings may not be dir-
ectly extended to private healthcare facilities. We re-
corded the duration of antibiotic treatment, but the
appropriateness and length of antibiotic use was not
assessed at the individual level, nor was the indication
for culture before antibiotic therapy. This could have
provided significant information to guide antibiotic
stewardships strategies and may be considered in future
surveys. Another limitation is the study’s time window.
Being a point prevalence study, information on antibiotic
use was collected at a single point in time over the
period between September and December 2016. This de-
sign would not capture the seasonality of infections and
antibiotic prescriptions. Conducting this survey through-
out multiple time points would have allowed for a more
robust estimate of inpatient antibiotic prescribing in
Ghana. However, we did not have the necessary capacity
to repeat this multi-site point prevalence study more
than once. Despite these limitations we believe the use
of standardized international protocol [23] for our study
gives us robust evidence of antibiotic use among hospi-
talized paediatric inpatients in Ghana and serves as a
bench mark for future comparison.
Conclusion
Our study shows high use of antibiotics among paediat-
ric inpatients in Ghana. It also highlights key differences
in antibiotic use among neonates and the other paediat-
ric population; neonates are likely to be prescribed an
aminoglycoside and a penicillin as opposed to the dom-
inant use of cephalosporins among the other age groups.
Studies of the appropriateness of antibiotic use are ur-
gently needed to guide antibiotic stewardship strategies
aiming at reducing the use of agents such as cephalospo-
rins in order to conserve their lifespan.
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